Enhanced complement susceptibility of avidin-biotin-treated human erythrocytes is a consequence of neutralization of the complement regulators CD59 and decay accelerating factor. (Q41809272)
Jump to navigation
Jump to search
scientific article published on May 1995
Language | Label | Description | Also known as |
---|---|---|---|
English | Enhanced complement susceptibility of avidin-biotin-treated human erythrocytes is a consequence of neutralization of the complement regulators CD59 and decay accelerating factor. |
scientific article published on May 1995 |
Statements
Enhanced complement susceptibility of avidin-biotin-treated human erythrocytes is a consequence of neutralization of the complement regulators CD59 and decay accelerating factor (English)
A B Zaltzman
C W Van den Berg
1 reference
1 reference
1 reference